Notably, the results demonstrated that the expression of TYK2 was more strongly correlated with the expression of the immune checkpoint genes, including PDCD1 (cor = 0.744) and TIGIT (cor = 0.705), in patients with HNSCC who were HPV-positive. The gene discussed is PDCD1; the disease is head and neck squamous cell carcinoma.